Therapeutic Effect of Immune Trioxy Autologous Blood Transfusion Combined with Ultrasound-Guided Paravertebral Injection of Trioxy in the Treatment of Postherpetic Neuralgia in Athletes
Keywords:
visual communicator; Immune trioxy autologous blood transfusion; Ultrasonic guidance; Herpes zoster; Clinical curative effectAbstract
Objective: To evaluate the clinical effectiveness of immune trioxy autologous blood transfusion combined with ultrasound-guided paravertebral injection of trioxy in treating postherpetic neuralgia (PHN) in athletes.
Methods: This study included 92 athletes with thoracolumbar PHN treated at our sports medicine clinic from January 2020 to January 2022. Participants were divided into two groups: the conventional treatment group (n=46), which received standard PHN therapies, and the combined treatment group (n=46), which underwent immune trioxy autologous blood transfusion and ultrasound-guided paravertebral trioxy injections. The study assessed the clinical efficacy, changes in pain intensity, and quality of life post-treatment.
Results: The combined treatment group exhibited a significantly higher total effective rate compared to the conventional treatment group (P<0.05). Visual Analog Scale (VAS) and Brief Pain Inventory (BPI) scores decreased markedly after treatment, with more significant reductions observed in the combined treatment group (all P<0.05). These improvements indicate a strong correlation between pain reduction and enhanced quality of life.
Conclusion: The combination of immune trioxy autologous blood transfusion and ultrasound-guided paravertebral trioxy injection is highly effective in managing thoracolumbar PHN in athletes. This therapeutic approach significantly alleviates pain and improves the quality of life, making it a valuable addition to clinical practices focusing on athlete health and recovery